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The burden of foodborne disease has large economic and social consequences
worldwide. Despite strict regulations, a number of pathogens persist within the food
environment, which is greatly contributed to by a build-up of resistance mechanisms
and also through the formation of biofilms. Biofilms have been shown to be highly
resistant to a number of antimicrobials and can be extremely difficult to remove once
they are established. In parallel, the growing concern of consumers regarding the
use of chemically derived antimicrobials within food has led to a drive toward more
natural products. As a consequence, the use of naturally derived antimicrobials has
become of particular interest. In this study we investigated the efficacy of nisin A
and its bioengineered derivative M21A in combination with food grade additives to
treat biofilms of a representative foodborne disease isolate of Listeria monocytogenes.
Investigations revealed the enhanced antimicrobial effects, in liquid culture, of M21A in
combination with citric acid or cinnamaldehyde over its wild type nisin A counterpart.
Subsequently, an investigation was conducted into the effects of these combinations on
an established biofilm of the same strain. Nisin M21A (0.1 µg/ml) alone or in combination
with cinnamaldehyde (35 µg/ml) or citric acid (175 µg/ml) performed significantly better
than combinations involving nisin A. All combinations of M21A with either citric acid or
cinnamaldehyde eradicated the L. monocytogenes biofilm (in relation to a non-biofilm
control). We conclude that M21A in combination with available food additives could
further enhance the antimicrobial treatment of biofilms within the food industry, simply
by substituting nisin A with M21A in current commercial products such as Nisaplin©R
(Danisco, DuPont).
Keywords: Listeria monocytogenes, biofilm, nisin, bioengineered, citric acid, cinnamaldehyde, combinations
INTRODUCTION
The globalization of food distribution and human travel (Tauxe, 2002; Hussain and Dawson, 2013)
has meant that foodborne disease can spread further and more rapidly than ever before, bypassing
conventional control measures (Koopmans et al., 2003; World Health Organization and Foodborne
Disease Burden Epidemiology Reference Group, 2007). The ability of bacterial pathogens to remain
viable in food production environments, even with the enforcement of stringent hygiene practices,
can be in part due to the accumulation of resistance mechanisms (Holah et al., 2002; Tauxe, 2002)
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and through the protection provided via the formation of
biofilms (Borucki et al., 2003; Ryu and Beuchat, 2005; Houdt and
Michiels, 2010). Surface-attached biofilms are sessile microbial
communities that can be irreversibly attached to a substratum
and are enclosed in an extracellular polymeric matrix (Donlan,
2002; Olszewska, 2013; Colagiorgi et al., 2016). Once formed,
biofilms can be extremely difficult to remove, leading to
contamination of processing equipment (Kumar and Anand,
1998; Tan et al., 2014), food spoilage and consequent economic
losses (Brooks and Flint, 2008; Houdt and Michiels, 2010).
Numerous studies have described the use of novel approaches to
control biofilms; these have included the use of biocides (Wood
et al., 1996), application of electrical currents (Poortinga et al.,
2001), temperature step changes during growth regions (Knight
et al., 2004), enzymes (Liu et al., 2014) and for biofilms on or
within a food matrix, the use of novel food additives (Furukawa
et al., 2010).
The use of bio-preservatives, as an alternative to chemical
food preservatives, has become more popular due to customer
demand for more natural and minimally processed foods (Lucera
et al., 2012). One such group of anti-bacterial preservatives
are bacteriocins. Bacteriocins are small, ribosomally synthesized
antimicrobials (Cleveland et al., 2001; Cotter et al., 2005; Gálvez
et al., 2007; Yang et al., 2014). Those derived from lactic acid
bacteria (LAB) have gained particular attention with respect to
their use in the food industry. One of the most extensively
studied bacteriocins is nisin A, a bactericidal lantibiotic produced
by some strains of Lactococcus lactis (Rouse et al., 2012;
Campion et al., 2013; Healy et al., 2013). It is a 3.5 kDa
peptide consisting of 34 amino acids and is a flexible and
elongated amphipathic peptide that has the ability to form
pores as well as inhibit cell wall biosynthesis (Breukink et al.,
1999; Wiedemann et al., 2001; Prudêncio et al., 2015). This
dual action of nisin has meant that despite widespread use in
the food industry, there have been few reports of resistance
development outside of the laboratory (Field et al., 2010b;
Molloy et al., 2012). Due to its proven range of antimicrobial
effects, nisin has been used as a food preservative for many
years (Breukink and de Kruijff, 1999; Elliason and Tatini, 1999;
Gálvez et al., 2007). Nisaplin R© is an example of a commercially
available food additive, containing 2.5% nisin. It is Generally
Regarded As Safe (GRAS) for several applications and has
been approved for use in the EU as preservative E234 by
Directive 95/2/EC (European Food Safety Authority, 2006) by
the U.S. Food and Drug Administration (FDA) (Prudêncio et al.,
2015) and by the WHO (Sobrino-López and Martín-Belloso,
2008).
Other examples of food additives are organic acids such
as lactic acid and citric acid (Young and Foegeding, 1993;
Helander and Mattila-Sandholm, 2000; Norhana et al., 2012),
salts of organic acids such as trisodium phosphate, potassium
sorbate, sodium benzoate and sodium diacetate (Phillips and
Duggan, 2001; Norhana et al., 2012) and proteins such
as lactoferrin (Branen and Davidson, 2004; Gálvez et al.,
2007) and nisin. Enhanced antimicrobial activity has been
successfully demonstrated against Gram-positive pathogens
when several of these antimicrobials were used in combination
with nisin (Phillips, 1999; McEntire et al., 2003; Branen and
Davidson, 2004; Bari et al., 2005; Murdock et al., 2007;
Norhana et al., 2012). Plant essential oils are another group
of additives that have gained increased attention due to
a long history of use for their antimicrobial effects and
the increased demand for more “natural” food products
(Helander et al., 1998; Burt, 2004; Bakkali et al., 2007;
Prudêncio et al., 2015). Essential oils are natural, volatile
liquids obtained from plant material (Gálvez et al., 2007)
that have aromatic qualities (Burt, 2004). A number of
studies have also been carried out that demonstrate the
enhanced antimicrobial activity of nisin in combination with
essential oils such as cinnamaldehyde (Field et al., 2015a)
and carvacrol (Pol and Smid, 1999) against a broad range of
pathogens including Gram-positive organisms, such as Listeria
monocytogenes and Bacillus cereus (Pol and Smid, 1999; Field
et al., 2015a), and Gram-negative bacteria, including Salmonella
enterica and Escherichia coli (Phillips and Duggan, 2001;
Govaris et al., 2010; Norhana et al., 2012; Prudêncio et al.,
2015).
The use of nisin in combination with other food preservatives
provides a hurdle approach to controlling pathogens while
reducing/removing the need for chemically synthesized
preservatives (Chalón et al., 2012). These benefits can be
further augmented through the use of bioengineered forms
of nisin. The gene encoded and ribosomally synthesized
nature of nisin has meant that nisin is a perfect candidate
for bioengineering, in order to enhance the functionality
of the peptide (Field et al., 2008; Molloy et al., 2012,
2013). Indeed, although there are numerous studies that
demonstrate the enhanced inhibitory activity of nisin when
used in combination with antimicrobial food additives, there
is little information pertaining to the use of bioengineered
nisin in combination with food additives to inhibit pathogens
within the food industry. Here, we demonstrate that the
use of a bioengineered derivative of nisin in combination
with a series of natural food additives results in enhanced
antimicrobial effects against L. monocytogenes, including
relatively antimicrobial resistant biofilms of this problematic
food borne pathogen.
MATERIALS AND METHODS
Growth of Bacterial Strains
Listeria monocytogenes F6854 strain, linked to a single case of
human illness traced to contaminated turkey frankfurters in 1988
(Nelson et al., 2004), was grown in Tryptic Soy Broth (TSB)
(Merck, Germany) or Tryptic Soy Agar (TSB substituted with
1.5% w/v agar) at 37◦C. L. lactis strains, L. lactis NZ9700, L. lactis
NZ9800-pCI372 Nisin A, L. lactis NZ9800-pCI372 M21A (Field
et al., 2008), L. lactis NZ9800–pCI372 AAA (Healy et al., 2013)
and L. lactis NZ9800-pCI372 Nisin V (Rouse et al., 2012), were
grown on M17 supplemented with 5% glucose (GM17) broth
(Oxoid, England) or GM17 agar (GM17 broth substituted with
1.5% w/v agar) at 30◦C. Strains were stocked in 40% glycerol and
stored at−20◦C.
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Deferred Antagonism Agar Diffusion
Assay
Agar diffusion assays was performed in triplicate as previously
described by Healy et al. (2013). Briefly, L. lactis strains producing
nisin A, M21A, AAA and Nisin V were spotted onto a GM17
agar plate and allowed to grow overnight. The plate was then
subjected to UV radiation for 30 min and then overlaid with
GM17 soft agar (0.75% w/v agar) seeded with 2% overnight of
L. monocytogenes F6854 and allowed to grow overnight at 37◦C.
Antimicrobial efficiency was determined through measurement
of the zone of inhibition using digital calipers.
Nisin Peptide Purification
Purification of nisin peptide was performed as described
previously by Campion et al. (2013). Briefly, TY broth (tryptone,
yeast extract, MnSO4H20, MgSO4) was passed through a column
(Length 70 cm, diameter 5 cm) one third packed with Amberlite
XAD-16 beads (Sigma). Resulting broth was dispensed in 900 ml
volumes and autoclaved. Overnight cultures of nisin producing
strains L. lactis NZ9800 – pCI372 M21A (for M21A production)
or L. lactis NZ9700 (for nisin A) were used to inoculate previously
filtered TY broth (2 × 900 ml) supplemented with 20% glucose
and 20% β-glycerophosphate. After overnight incubation at
30◦C, the culture was centrifuged at 8500 g at 4◦C for 20 min
(Thermo Scientific, SorvallTM RC 6+ Centrifuge, USA). Culture
supernatant was passed dropwise through a column containing
60 g Amberlite XAD-16 beads and discarded. Following a 500 ml
wash of 30% ethanol the nisin was eluted from the column using
500 ml of 70% isopropanol (Fisher Scientific, UK) supplemented
with 0.1% trifluoroacetic acid (TFA). Concurrently bacterial cell
pellets were resuspended in 300 ml 70% isopropanol – 0.1% TFA.
Following stirring at room temperature for 3 h the suspension
was centrifuged at 8500 g at 4◦C for 15 min and supernatant
was retained. The column eluant was pooled with the post-
centrifugation supernatant and concentrated to a volume of
300 ml using rotary evaporation (BÜCHI Rotavapor R-205,
Switzerland). The pH of the sample was adjusted to pH 4.0
and it was subsequently passed through a 60 ml Strata C-18 E
column (Phenomenex) that was previously washed with 60 ml
methanol (Fisher Scientific, UK) and 60 ml H2O. After applying
120 ml 30% ethanol, nisin was eluted from the column using
60 ml 70% isopropanol – 0.1% TFA and stored at 4◦C. For HPLC
purification 10 ml volumes were concentrated to a volume of
∼2 ml by rotary evaporation and injected into a HPLC system
(Shimadzu) equipped with a Phenomenex C12 Reverse-Phase
(RP) column (Jupiter 4 µ proteo 90 Å, 250 mm × 10.0 mm,
4 µm). Nisin was eluted via a gradient of 30–50% acetonitrile
(Fisher) containing 0.1% TFA that was developed over 5–40 min.
Nisin containing fractions were pooled, acetonitrile was removed
by rotary evaporation and the peptide was lyophilised and stored
at−20◦C.
Minimum Inhibitory Concentration
Determination
Minimum inhibition concentrations (MIC) of peptides and
antimicrobials were determined using 96 well microtitre plates
following CLSI (Clinical and Laboratory Standards Institute)
guidelines as previously described by Draper et al. (2013) with
some modifications. Briefly, each well within the microtitre plate
was treated with phosphate buffered saline (PBS) containing 1%
(w/v) bovine serum albumin (PBS/BSA) (200 µl) and incubated
for 30 min at 37◦C. Following this, the wells were washed
with PBS (200 µl) and allowed to dry. Overnight cultures of
L. monocytogenes F6854 were then sub-cultured into fresh broth
and grown to an OD600 of 0.5 [∼108 colony forming units
(cfu)/ml] and subsequently diluted to a final concentration of
∼105 cfu/ml. Stock concentrations of nisin A (100 µg/ml),
nisin M21A (128 µg/ml), Nisaplin R© (25 mg/ml), and citric acid
(150 µg/ml) were prepared in TSB, while 99%-cinnamaldehyde
(10 mg/ml) was prepared in a 50% ethanol solution. Each
antimicrobial was subjected to twofold serial dilutions in TSB in
the PBS/BSA treated plate and the appropriately diluted F6854
strain was subsequently added (100 µl). 96 well microtitre plates
were incubated overnight at 37◦C. Each MIC was performed in
triplicate. The MIC was determined as the lowest concentration
at which there was no visible growth.
Growth Curves
Growth curves were performed in a checkerboard assay manner
in 96 well microtitre plates. A twofold serial dilution of either
nisin A or nisin M21A were performed along the abscissa
excluding the final row. In a separate 96 well microtitre
plate, serial twofold dilutions of the antimicrobials sodium
acetate, sodium benzoate (both food grade, Sigma), citric
acid, potassium sorbate, carvacrol, lactoferrin and 99% trans-
cinnamaldehyde (hereafter referred to as cinnamaldehyde)
(all research grade, Sigma) and Nisaplin R© (Danisco, DuPont
Nutrition and Health) were performed separately along the
ordinate excluding column 1. These dilutions were directly
transferred into the corresponding wells on the original plate.
100 ml of a 2% inoculum from an overnight strain was
added to each well on the plate. Cell growth was measured
spectrophotometrically over a 24 h period using MWGt Sirius HT
plate reader (BioTek Instruments, USA).
Biofilm Growth
Biofilm growth was performed as previously described by
Field et al. (2015a), but with modifications as follows. TSB
supplemented with 1% D-(+)-glucose (Sigma) (TSBg) was used
in order to aid biofilm formation (Choi et al., 2013). 200 µl
of TSBg containing a final concentration of 2% inoculum
from an overnight strain was added to test wells of a sterile
PBS/BSA treated 96 well microtitre plate (Starstedt, Germany).
Additionally, 200 µl of TSBg was added to control wells as a
negative control. Plates were incubated at 37◦C for 48 h to allow
for biofilm attachment and formation.
Established Biofilm Treatment
Biofilm inhibition assays were carried out as previously described
by Field et al. (2015b). Here, nisin A, nisin variant M21A,
Nisaplin R©, citric acid and 99% cinnamaldehyde were used
to treat L. monocytogenes F6854 biofilms. By combining a
variety of concentrations of the aforementioned antimicrobials,
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the minimum amounts needed in combination for effective
treatment of an F6854 biofilm was established as follows;
100 µl of the appropriate concentration for each peptide and/or
antimicrobial in TSB were added to the biofilm, both alone
and in combination. TSB alone was added to a set of wells
as a negative control. A number of biofilm containing wells
(labeled untreated) and wells containing TSB alone (labeled
control) were left untreated and the plate was incubated at
37◦C for 24 h. In order to determine the metabolic activity
of the biofilm after antimicrobial treatment an XTT assay
was performed as previously described by Field et al. (2015b).
The principle of the XTT assay is that viable cells will
reduce the tetrazolium salt XTT [2,3-bis(2-methyloxy-4-nitro-
5-sulfophenyl)-2H-tetrazolium-5 carboxanilide] (Sigma) to an
orange-colored water-soluble product measurable via a standard
microplate absorbance reader at OD492 nm (Tunney et al., 2004).
Briefly, all test and control wells were washed with 200 µl sterile
PBS. 100 µl of a solution containing 500 mg/l XTT sodium salt
and 10µM menadione (Sigma) was added to each well. The plates
were incubated in darkness at 37◦C for 2 h. Absorbance was read
at 492 nm.
Statistical Analysis
All aforementioned growth curve experiments were conducted
in triplicate. Six replicates of each established biofilm treatment
experiment were performed. Statistical analysis was performed
using GraphPad Prism 6, GraphPad Software, Inc. Unless
otherwise stated a one-way ANOVA was performed followed by
Tukey test, where P-values are denoted as: ∗P > 0.05; ∗∗P ≤ 0.01;
∗∗∗P ≤ 0.001.
RESULTS
Deferred Antagonism Agar Diffusion
Assay
In order to evaluate the antimicrobial activity of nisin A and its
derivatives against L. monocytogenes F6854, a selection of nisin
variant producers were assessed via deferred antagonism agar
diffusion assay. Of the variant strains tested the observed zone
sizes for three derivative producers, AAA (where the three hinge
amino acids in positions 20–22 have been replaced with alanines),
M21A and M21V were consistently enhanced when compared to
the corresponding isogenic nisin A producer (Figure 1). To date
a number of studies have been conducted that have highlighted
the efficacy of M21V against strains of L. monocytogenes (Field
et al., 2008, 2015a; Campion et al., 2013). Here, we noted that
the antimicrobial efficiency of the M21A producer appeared
equivalent to that of M21V, while they both had a greater degree
of activity against the indicator strain than that of the producer
of the AAA derivative. As a result of these observations the
purified nisin M21A peptide was chosen for further investigation
via specific activity studies/growth curve experiments.
Minimum Inhibitory Concentrations
The activities of purified nisin A, nisin M21V and M21A
were assessed using broth based MIC assays (Table 1). The
MIC recorded for nisin A against L. monocytogenes F6854
was 12.5 µg/ml, a result that is consistent with previously
published results for L. monocytogenes EGDe::pPL2luxpHELP
(Campion et al., 2013). The MIC for both nisin M21V and
M21A was 6.25 µg/ml, i.e., half that observed for nisin A.
Indeed, it has previously been established that nisin M21V
has twofold greater activity than nisin A against a number of
L. monocytogenes (Field et al., 2010a; Molloy et al., 2012). In
addition to nisin and its variants, the antimicrobial activity of
citric acid, sodium acetate, sodium benzoate, potassium sorbate,
carvacrol, lactoferrin, cinnamaldehyde and Nisaplin R© against
F6854 were also assessed (Table 1).
Dual Antimicrobial Inhibition of L.
monocytogenes F6854
Preliminary checkerboard assays combining nisin A and M21A
with each of the other, aforementioned, antimicrobials were
performed in order to determine if any of the combinations
revealed enhanced antimicrobial activity. While many
combinations showed marginally enhanced effects (data
not shown), the combination of nisin A, M21A and either citric
acid or cinnamaldehyde showed the most dramatic results.
Therefore, further triplicate growth curve experiments were
conducted using both nisin A and M21A in combination with
either citric acid or cinnamaldehyde against L. monocytogenes
F6854 over a 24 h period (Figures 2 and 3). At 0.78 µg/ml,
neither nisin peptide inhibited the pathogen. Citric acid, at
1170 µg/ml, extended the lag phase by approximately 1 h
and reduced the final OD. Combining these concentrations
of nisin A and citric acid extended the lag phase by 14 h and
an OD600 nm of 0.3 was only reached after 22 h. When citric
acid (1170 µg/ml) was combined with M21A (0.78 µg/ml),
complete inhibition of growth was observed (Figure 2). An
enhanced specific activity of M21A in comparison to nisin A was
also noted during combinatorial studies with cinnamaldehyde
against L. monocytogenes F6854 (Figure 3). 117.2 µg/ml of
cinnamaldehyde alone delayed the lag phase by approximately
2 h but, when combined with M21A (0.78 µg/ml) the lag
phase was extended to 11 h, approximately 4 h longer than that
observed for nisin A and cinnamaldehyde.
Biofilm Treatment
These combinations were examined to determine if they
also demonstrated enhanced efficacy against established F6854
biofilms (Figures 4 and 5). It was observed that for biofilm
treatment the ratio (µg/ml: µg/ml) of cinnamaldehyde or citric
acid to nisin A or M21A was in some case 150 times the ratio used
for planktonic growth inhibition (Table 2). Cinnamaldehyde
(35 µg/ml) and M21A (0.1 µg/ml) showed significantly enhanced
antimicrobial effects against the established biofilm compared
to the corresponding combinations of cinnamaldehyde and
nisin A. Biofilm treatment with citric acid (175 µg/ml) and
M21A (0.1 µg/ml) in combination reduced the viable cell
numbers significantly compared to the antimicrobial/peptide
alone (Figure 5). Most striking was the significant fivefold
difference observed between the nisin A-citric acid combination
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FIGURE 1 | Agar diffusion assays depicting the antimicrobial effects of Lactococcus lactis NZ9800 strains producing the mutants M21V, M21A, AAA
and nisin A (wild type) against Listeria monocytogenes F6854. Diameter zone sizes (mm) are the average of triplicate experiments.
TABLE 1 | Minimum inhibitory concentrations of nisin peptides and
antimicrobials required to treat L. monocytogenes F6854.
Antimicrobial MIC (µg/ml)
Nisin A 12.5
Nisin V 6.25
M21A 6.25
Citric Acid 2340
99% cinnamaldehyde 625
Lactoferrin >2500
Sodium acetate 250,000
Sodium benzoate 25,000
Carvacrol 310
Potassium sorbate 37,500
Nisaplin R© 393
and the dual effect of M21A and citric acid. Notably, when
used at these concentrations the impact of the nisin derivative
M21A in combination with either citric acid or cinnamaldehyde
was statistically indistinguishable from the non-biofilm control,
indicating complete eradication of the biofilm.
Inhibitory Effect of Nisaplin R© in
Combination with Antimicrobials on
F6854 Biofilm
It was decided to investigate if inhibitory effects were achievable
using citric acid and cinnamaldehyde in combination with a
readily available nisin A containing food additive Nisaplin R©.
With the enhanced inhibitory effects of M21A over nisin A
evident in the previous combination studies, a greater amount of
nisin A and hence Nisaplin in combination would be required
to cause eradication of an established biofilm. This would
suggest that production of a derivative of Nisaplin R©-equivalent
containing M21A would enhance the antimicrobial potency of
these additives. Since Nisaplin R© contains only 2.5% nisin it was
of interest to confirm that the remainder of the ingredients within
this additive (or a potential M21A containing product) would not
inhibit the observed synergy with citric acid and cinnamaldehyde.
As seen in Figure 6 a presumptive synergistic effect was observed
between Nisaplin R© and cinnamaldehyde against an established
F6854 biofilm (Figure 6). Neither Nisaplin R© [30 µg/ml (nisin A
content: 0.75 µg/ml)] nor cinnamaldehyde (15 µg/ml) alone had
a statistically significant effect on the biofilm in relation to the
untreated control. However, the dual effect of both antimicrobials
at the same concentrations showed a statistically significant
decrease in the biofilm. A similar result was observed when
Nisaplin R© (30 µg/ml (nisin A content: 0.75 µg/ml)) and citric
acid (125 µg/ml) were combined (Figure 7). Neither Nisaplin R©
nor citric acid alone had a statistically significant effect on the
biofilm. However, the combination of both antimicrobials at the
same concentrations showed a statistically significant (P≤ 0.001)
decrease in biofilm viability. When we consider the nisin A
content of the Nisaplin R© used (30 µg/ml) in these combinations
it corresponds to 0.75 µg/ml (2.5%). This is >7 times the
amount of purified M21A peptide utilized in the corresponding
combinations (Figures 4 and 5) to achieve biofilm eradication.
It must be noted however that the levels of citric acid and
cinnamaldehyde utilized were slightly decreased (1.4 and 2.3
times respectively) in comparison to the aforementioned M21A
containing biofilm treatments.
DISCUSSION
Listeriosis, the disease associated with the ubiquitous food borne
pathogen L. monocytogenes, has a low incidence rate (Maertens
de Noordhout et al., 2014), but an extremely high mortality
rate (20–30%) (Laksanalamai et al., 2012) and is rigorously
monitored within the food and beverage industry. Microbial
standards within the EU state that <100 cfu/g L. monocytogenes
is permitted in Ready-To-Eat (RTE) foods that do not have
the potential to support listerial growth throughout their shelf
life. However, in infant foods, foods for medical purposes and
RTE foods that do support listerial growth, the micro-organism
must be absent in any 25 g sample at the time of production
(The Commission of the European Communities, 2005). The
US maintain a zero tolerance policy on L. monocytogenes in
any RTE product (And and Hoover, 2003). Due to these highly
strict regulations, discovering novel and safe means to control of
L. monocytogenes is of significant importance and benefit to food
manufacturers.
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FIGURE 2 | Growth curve depicting the effect of both M21A and Nisin A (Nis A) alone and in combination with citric acid (CA) against
L. monocytogenes F6854. Growth was measured via triplicate readings at OD600 nm over a period of 22 h.
FIGURE 3 | Growth curve depicting the effect of both M21A and Nisin A (Nis A) alone and in combination with cinnamaldehyde (CN) against
L. monocytogenes F6854. Growth was measured at OD600 nm over a period of 24 h. Results were recorded in triplicate.
The main focus of this study was to determine if an
enhanced effect could be obtained by combining a derivative
of nisin with other food-grade antimicrobials to inhibit the
growth of L. monocytogenes F6854 in liquid culture and, in
addition, to eradicate established biofilms of this same strain.
By including bioengineered versions of nisin in this study
we sought to and achieved increased antimicrobial potency.
Due to the documented sensitivity of Listeria to nisin and
the relevance of both to the food industry (Thomas and
Wimpenny, 1996; Arqués et al., 2008; Pinto et al., 2010;
Field et al., 2015a), strain F6854, which has been linked to
contaminated turkey frankfurters, represented an ideal target
for nisin and food-grade antimicrobial combinations. The food
additives sodium benzoate, sodium acetate, potassium sorbate,
lactoferrin, carvacrol, citric acid and cinnamaldehyde were all
tested initially. We noted that the amount of sodium acetate
required for inhibition was extremely high as compared to the
other antimicrobials in this study. The MIC obtained for both
sodium benzoate and potassium sorbate are higher than that
previously reported for other L. monocytogenes strains (Neetoo
et al., 2008). In addition, the concentration of cinnamaldehyde
required to inhibit the indicator strain was found to be 625µg/ml.
This is approximately 50% greater than the MIC previously
published for cinnamaldehyde against a number of different
L. monocytogenes strains. The MIC for carvacrol was, however,
in keeping with results targeting two strains from this same
study (Field et al., 2015a). Following initial broth-based growth
curves the most notable effects were observed however when
citric acid or cinnamaldehyde were used in combination with
nisin.
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FIGURE 4 | Treatment of an established F6854 biofilm – NisA and M21A
in combination with cinnamaldehyde. Treatment of established (48 h)
biofilms of L. monocytogenes F6854 with M21A, nisin A (Nis A) and
cinnamaldehyde (CIN) alone and in combination. Treatment was performed in
triplicate over 24 h. Graph indicates the level of metabolically viable cells
remaining following treatment as determined through XTT assay.
∗∗P-value ≤ 0.01; ∗∗∗P-value ≤ 0.001.
Citric acid has a long history of use in food and has
GRAS status (Lemmerer and Bernstein, 2010). It is used for its
antimicrobial properties, which includes its ability to function
as a chelator (Brul and Coote, 1999) and to pass freely through
the cell membrane altering the cytoplasmic pH (Cotter and Hill,
2003). It is often used in combination with other preservatives
and/or antimicrobials to inhibit pathogens in food. Indeed, the
use of citric acid has proven effective in combination with
nisin against Gram-negative bacteria (Phillips, 1999) and in
combination with nisin against a strain of Listeria innocua
(Al-Holy et al., 2006). Less is known about the effect of
citric acid on L. monocytogenes. Cinnamaldehyde has previously
been shown to have an antimicrobial effect on strains of
L. monocytogenes (Gill and Holley, 2004). Although not fully
elucidated, cinnamaldehyde is believed to function through
inhibition of glucose uptake, inhibition of enzymes involved in
cell function and disruption of the cell membrane (Gill and
Holley, 2004; Hyldgaard et al., 2012). Furthermore, a recent study
by Field et al. (2015a) also demonstrated that cinnamaldehyde
in combination with a nisin variant was more effective than the
essential oil or variant alone against a strain of L. monocytogenes
in planktonic form.
Following the selection of two antimicrobial compounds,
cinnamaldehyde and citric acid, we investigated the consequences
of their use in combination with nisin A or a bioengineered
derivative thereof. From a number of nisin A variants tested,
both M21A and M21V demonstrated equally enhanced activity
compared to the wild type in both MIC and agar diffusion assays.
Nisin A derivatives M21A and M21V both contain a single amino
acid changes at position 21. In the case of M21A, a methionine
is replaced by an alanine and in M21V, the same methionine
is replaced by a valine. M21V has previously demonstrated
enhanced activity against strains of L. monocytogenes and has
been documented in numerous studies (Field et al., 2010b, 2015a;
Campion et al., 2013; Healy et al., 2013) and so it was included in
MIC studies in order to compare its activity with that of M21A,
which until now remained relatively undocumented. This is the
first study in which the MIC of the bioengineered derivative
M21A has been tested against a strain of L. monocytogenes.
Having established that the antimicrobial efficacy of M21A
against L. monocytogenes F6854 was twofold greater than that of
nisin A, we went further to demonstrate that M21A possesses
enhanced ability when compared to the wild type with respect
to eradicating formed L. monocytogenes biofilms, a characteristic
not attributed to any other bioengineered nisin derivative to date.
Initially inhibition of bacterial growth utilizing the chosen
food-grade additives (citric acid and cinnamaldehyde) and
lantibiotic peptides nisin A and M21A were investigated using
broth based growth curve assays. These studies demonstrated
that complete inhibition of this strain of F6854 could be
obtained using M21A in combination with citric acid, while
nisin A at the same concentrations was unable to achieve such
potency. Although a less dramatic result was obtained from the
combination of M21A and cinnamaldehyde, M21A exhibited a
greater inhibitory effect against L. monocytogenes F6854 both
alone and in combination with cinnamaldehyde. Hence, the
anti-listerial properties of M21A can be further enhanced with
the addition of citric acid or cinnamaldehyde. This led to
investigation to determine if these enhanced effects could also
inhibit established biofilms of the same strain.
TABLE 2 | Ratio of antimicrobials used in combination to treat L. monocytogenes F6854 in both planktonic culture and as established biofilms.
Antimicrobial combinations Planktonic culture Established biofilm
(µg/ml: µg/ml) Ratio (µg/ml: µg/ml) Ratio
Nisin A: citric acid 0.78:1170 1:150 0.1:175 1:1750
Nisin A: cinnamaldehyde 0.78:117.2 1:150∗ 0.1:35 1:350
M21A: citric acid 0.78:1170 1:150 0.1:175 1:1750
M21A: cinnamaldehyde 0.78:117.2 1:150∗ 0.1:35 1:350
These ratios are based on the minimum concentration (µg/ml) of each antimicrobial required in combination to inhibit F6854.
∗Complete inhibition of L. monocytogenes was not achieved in this case.
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FIGURE 5 | Treatment of an established F6854 biofilm – NisA and M21A
in combination with citric acid. Treatment of established (48 h) biofilms of
L. monocytogenes F6854 with M21A, nisin A (Nis A) and citric acid (CA) alone
and in combination. Treatment was performed in triplicate over 24 h. Graph
indicates the level of metabolically viable cells remaining following treatment as
determined via XTT assay. ∗∗P-value ≤ 0.01; ∗∗∗P-value ≤ 0.001.
FIGURE 6 | Treatment of an established F6854 biofilm – Nisaplin R© and
cinnamaldehyde. Treatment of established (48 h) biofilms of
L. monocytogenes F6854 with Nisaplin R© and cinnamaldehyde (CN) alone and
in combination. Treatment was over 24 h and performed in triplicate. Graph
indicates the level of metabolically viable cells remaining following treatment as
determined through XTT assay. ∗∗∗P-value ≤ 0.001.
Nisin has been used in previous studies with a view to
inhibiting bacterial biofilms (Mahdavi et al., 2007; Gou et al.,
2011). In addition, nisin in combination with antimicrobials has
also been investigated in relation to the inhibition of bacterial
FIGURE 7 | Treatment of an established F6854 biofilm – Nisaplin R© and
citric acid. Treatment of established (48 h) biofilms of L. monocytogenes
F6854 with Nisaplin R© and citric acid alone and in combination. Treatment was
over 24 h and performed in triplicate. Graph indicates the level of metabolically
viable cells remaining following treatment as determined via XTT assay.
∗∗∗P-value ≤ 0.001.
biofilms and more recently the use of a nisin derivative has
been investigated in relation to the inhibition of a Staphylococcus
biofilm (Field et al., 2015b). However, the current study is
the first to our knowledge to show the antimicrobial effects
of a bioengineered version of nisin (both alone and in
combination) on L. monocytogenes biofilms. The demonstrated
enhanced antimicrobial effect of M21A in combination with
food grade preservatives, citric acid or cinnamaldehyde, resulted
in a reduction in viable cells that could not be statistically
distinguished from a non-biofilm control.
When we examined the concentrations of antimicrobials
required to obtain inhibition we observed the same trend for
planktonic and biofilm experiments, with a low level of nisin and
a greater amount of citric acid/cinnamaldehyde required. When
we examine the ratio of antimicrobial concentrations used for
biofilm inhibition the level of cinnamaldehyde and citric acid
required to treat the biofilms is up to 150 times that required
for planktonic cells. This confirms that determining the ideal
proportion of each antimicrobial is vital for optimal synergistic
effect and is dependent on the physiological state of bacteria
whether it be planktonic or existing as a biofilm. It is also possible
that the structural properties of the extracellular polymeric
matrix or subtle differences in the behavior of cells within the
biofilm occur in comparison to their planktonic counterparts. In
fact, it has been shown that lower levels of Nisaplin R© are required
to inhibit L. monocytogenes within a food matrix when compared
to broth based assays (Hara et al., 2009).
Currently, nisin A-containing products such as Nisaplin R© are
commercially available to be used as food preservatives. Here,
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we show that Nisaplin R©-citric acid/cinnamaldehyde combi-
nations could significantly reduce and in fact eradicate Listeria
biofilms. However, >7 times more of the antimicrobial
component (i.e., nisin A) was required in comparison to
the M21A purified peptide counterpart. Nonetheless due to
market availability of Nisaplin R© and these food additives, such
combinations are readily applicable and may even present a lower
cost alternative to the control of L. monocytogenes within the
food industry. Although, nisin sensitivity to L. monocytogenes has
been documented, the development of nisin resistant mutants
has been reported (Gandhi and Chikindas, 2006). Therefore, the
combinations within this study represent an example of hurdle
technology whereby bacterial growth struggles to overcome
the potency of dual acting antimicrobials. In addition, by
combining these antimicrobials it allows for the use of lower
concentrations of the individual additives in food items. This
may prove beneficial in relation to the use of the essential oil
cinnamaldehyde – the use of which has been limited due to the
amount needed for an antimicrobial effect affecting the overall
organoleptic properties of the food itself. However, sensory
evaluation of a chosen food containing this level of the essential
oil or citric acid should be conducted in order to distinguish if
there are any negative effects to the organoleptic properties of the
food.
Ultimately, this study has identified a clear application for
M21A in combination with either citric acid or cinnamaldehyde
to inhibit listerial growth, eradicate formed biofilms and hence
potentially inhibit biofilm formation. This effect that significantly
exceeded the effect of nisin A in the corresponding combination.
This study documents the first report of a bioengineered
derivative of nisin used with other food additives to control
Listeria biofilms. We propose that substituting M21A into nisin
A-containing products, such as Nisaplin R©, would further enhance
the antimicrobial potency of such products. Ultimately, such
combinations should enhance the microbial safety of foods as
well as provide consumers with an effective natural alternative to
artificial preservatives.
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